Recombinant PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) Antibody, Clone: [MSVA-711R], Rabbit, Monoclonal

Artikelnummer: NBT-29126-RBM30-P0
Artikelname: Recombinant PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) Antibody, Clone: [MSVA-711R], Rabbit, Monoclonal
Artikelnummer: NBT-29126-RBM30-P0
Hersteller Artikelnummer: 29126-RBM30-P0
Alternativnummer: NBT-29126-RBM30-P0-20
Hersteller: NeoBiotechnologies
Wirt: Rabbit
Kategorie: Antikörper
Applikation: IHC
Spezies Reaktivität: Human
Immunogen: KLH-conjugated linear peptide corresponding to human PD-L1
Alternative Synonym: B7 homolog 1, B7-H1, CD274, PD-L1, PDCD1 ligand 1, PDCD1L1, PDCD1LG1, Programmed cell death 1 ligand 1
PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.
Klonalität: Monoclonal
Klon-Bezeichnung: [MSVA-711R]
Molekulargewicht: 37-50kDa
NCBI: 29126
UniProt: Q9NZQ7
Formulierung: Ab produced in CHO cell mammalian-based expression system. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide.
Programmed cell death 1 ligand 1 Rabbit Recombinant Monoclonal Antibody (MSVA-711R) tested on many normal and cancer tissues. The immunohistochemistry staining in these tissues aligns with the expression data in Human Protein Atlas.